Vijaya Gadde's most recent trade in Planet Labs PBC - Ordinary Shares - Class A was a trade of 20,000 Class A Common Stock done at an average price of $26.8 . Disclosure was reported to the exchange on Jan. 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Sale of securities on an exchange or to another person at price $ 26.77 per share. | 22 Jan 2026 | 20,000 | 250,169 | - | 26.8 | 535,350 | Class A Common Stock |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 270,169 | - | 0 | Class A Common Stock | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 6,833 | 6,833 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 4,203 | 4,203 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,674 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,674 | 24,314 (0%) | 0% | 0 | Common Stock | |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 93,583 | 237,701 | - | 0 | Class A Common Stock | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,703 | 10,703 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 6,674 | 6,674 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 5,592 | 17,640 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 5,592 | 0 | - | - | Restricted Stock Units | |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 54,055 | 103,577 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 40,541 | 144,118 | - | 0 | Class A Common Stock | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 8,803 | 8,803 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 5,592 | 5,592 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 5,531 | 12,048 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 5,531 | 0 | - | - | RESTRICTED STOCK UNITS | |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 37,808 | 49,522 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2022 | 11,714 | 11,714 | - | 0 | Class A Common Stock | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 8,789 | 8,789 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,531 | 5,531 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,814 | 0 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Vijaya Gadde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,814 | 6,517 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 3,135 | 3,135 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 1,814 | 1,814 | - | - | RESTRICTED STOCK UNITS |